ARCHIVES

First Compound From New In Vitro Screening to Enter Clinical Trials

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

ACCC Unit Reaches Consensus On Outline of HOP; Each Member Would Relate To Center Or Cooperative Group

September 11, 1981

Don’t Blame FDA For All Problems, Broder Says

September 7, 1990

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

NCI To Lose 19% of Workforce Over Six Years, Broder Says

November 4, 1994

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

May 5, 1995

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013